NEW YORK (GenomeWeb) – Olink AB announced today that it has completed a reorganization and has split into two separate companies — Olink Proteomics and Olink Bioscience.

Olink Proteomics will continue to expand and develop the Proseek Multiplex human protein biomarker discovery product portfolio and is aiming to create a variety of high-quality multiplex immunoassays for biomarker discovery as well as diagnostic tools based on clinically relevant protein signatures.